The Cleveland Clinic and Greatbatch Medical- backed neuromodulation device developer is targeting a $9.6m close according to a securities filing.
Cardionomic, a US-based neuromodulation device developer backed by healthcare provider Cleveland Clinic and medical device producer Greatbatch Medical, has received $9m in funding from undisclosed investors according to a securities filing.
The capital was supplied as part of a round with a $9.6m target, according to the filing. The company had previously raised $20m in a 2015 series A round featuring Cleveland Clinic, Greatbatch Medical, venture capital firm New Enterprise Associates and undisclosed other investors.
Cardionomic is developing a…
